Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company's pipeline includes treatments for Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Denali Therapeutics uses a proprietary technology platform to develop drugs that can cross the blood-brain barrier, which is a major challenge in treating neurological disorders. The company was founded by a team of scientists with extensive experience in drug development and neuroscience research.